Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer
Recruiting · NCT06984250 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Hypofractionated breast radiotherapy with concomitant tumor bed boost for early breast cancer or ductal breast carcinoma in situ after partial mastectomy
Who can take part
Age range
20 Years to 85 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Female patients with histologically confirmed early-stage breast cancer (T1-2 and N0-1) or ductal carcinoma in situ (DCIS).
- Patients undergoing breast-conserving surgery
- Age ≥ 20 years
- Karnofsky Performance Status (KPS) ≥70%
- Life expectancy ≥ 5 years
- Adequate renal and hepatic function
Exclusion criteria
- Pregnant patients
- Patients requiring re-irradiation of the thoracic region
Where it is running
2 locations listed.
- National Taiwan University Hospital Yunlin Branch - Taipei, Taiwan
- National Taiwan University Hospital - Taipei, Taiwan, Taiwan